Director, Liu Center for Pulmonary Hypertension
Cardiology
Dr. Ronald J. Oudiz, MD
|
|
Give Review
Dr. Ronald J. Oudiz works in the field of Cardiology. He studied medicine at Keck School of Medicine of USC. Keck School of Medicine of USC is ranked 31/72 in Research/PrimaryCare. He over the years received 3 awards: "Fellow (FACP)", "Fellow (FACC)" and "Super Doctor". Ronald J. Oudiz, MD is a published doctor and has 76 publications published. The lastest was: 'Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Right heart adaptation to Pulmonary arterial hypertension: physiology and pathobiology.
- Updating clinical endpoints in Pulmonary arterial hypertension: when challenges are welcome.
- Pulmonary Vascular Hemodynamic Response to Exercise in Cardiopulmonary Diseases.
- Death in Pulmonary arterial hypertension.
- Contemporary trends in the diagnosis and management of Pulmonary arterial hypertension: an initiative to close the care gap.
- Updating clinical endpoint definitions.
- Tadalafil for the Treatment of Pulmonary Arterial Hypertension: A Double-Blind 52-Week Uncontrolled Extension Study.
- Long-Term Pulmonary Hemodynamic Effects of Ambrisentan in Pulmonary Arterial Hypertension.
- Compelling evidence of long-term outcomes in Pulmonary arterial hypertension? A clinical perspective.
- Usefulness of right-to-left shunting and poor exercise gas exchange for predicting prognosis in patients with Pulmonary arterial hypertension.
- Developing Pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardioPulmonary exercise testing.
- Exercise training in patients with Pulmonary arterial hypertension: a case report.
- Diagnosis and assessment of Pulmonary arterial hypertension.
- End points and clinical trial design in Pulmonary arterial hypertension.
- Dosing considerations in the use of intravenous prostanoids in Pulmonary arterial hypertension: an experience-based review.
- Ambrisentan therapy in patients with Pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.
- Successful tricuspid Valve replacement in a patient with severe pulmonary arterial hypertension and preserved right ventricular systolic function.
- Exercise-induced pulmonary arterial hypertension: a new addition to the spectrum of pulmonary vascular Diseases.
- Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.
- Sitaxsentan treatment for patients with Pulmonary arterial hypertension discontinuing bosentan.
- Complications of right heart catheterization procedures in patients with Pulmonary hypertension in experienced centers.
- Randomized study of adding inhaled iloprost to existing bosentan in Pulmonary arterial hypertension.
- Temporal trends and drug exposures in Pulmonary hypertension: an American experience.
- Noninvasive gadolinium-enhanced three dimensional computed tomography Coronary angiography.
- Detection of small vessels with electron beam computed tomographic angiography using 1.5 and 3 mm collimator protocols.
- CardioPulmonary exercise testing and six-minute walk correlations in Pulmonary arterial hypertension.
- Coronary venous imaging with electron beam computed tomographic angiography: three-dimensional mapping and relationship with Coronary arteries.
- The role of exercise testing in the management of Pulmonary arterial hypertension.
- End-tidal PCO2 abnormality and exercise limitation in patients with primary Pulmonary hypertension.
- Comparison of Coronary artery calcium screening image quality between C-150 and e-Speed electron beam scanners.
- Clinical efficacy of sildenafil in primary Pulmonary hypertension.
- Micrococcus-associated central venous catheter infection in patients with Pulmonary arterial hypertension.
- End points and clinical trial designs in Pulmonary arterial hypertension: clinical and regulatory perspectives.
- Pulmonary artery systolic pressure estimated by echocardiogram vs catheterization in patients awaiting lung transplantation.
- Measurement of the RT interval on ECG records during electron-beam CT.
- Pulmonary function in primary Pulmonary hypertension.
- Sensitivity to detect small Coronary artery calcium lesions with varying slice thickness using electron beam tomography.
- Reproducibility of three different scoring systems for measurement of Coronary calcium.
- Gas exchange detection of exercise-induced right-to-left shunt in patients with primary Pulmonary hypertension.
- Secondary Pulmonary Hypertension.
- Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue Disease.
- Efficacy and safety of treprostinil: an epoprostenol analog for primary Pulmonary hypertension.
- Serial hemodynamics and complications of pregnancy in severe Pulmonary arterial hypertension.
- Effect of sildenafil on ventilatory efficiency and exercise tolerance in Pulmonary hypertension.
- Prevalence of obstructive Coronary artery disease in an outpatient cardiac CT angiography environment.
- Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue Disease.
- Tadalafil therapy for Pulmonary arterial hypertension.
- Ambrisentan for the treatment of Pulmonary arterial hypertension: results of the ambrisentan in Pulmonary arterial hypertension, randomized, double-blind, placebo-cont...
- Long-term ambrisentan therapy for the treatment of Pulmonary arterial hypertension.
- Tadalafil monotherapy and as add-on to background bosentan in patients with Pulmonary arterial hypertension.
- The Pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated ...
- Minimal alpha 1- and alpha 2-adrenoceptor-mediated Coronary vasoconstriction in the anaesthetized swine.
- Effect of electrocardiogram triggering on reproducibility of Coronary artery calcium scoring.
- Exercise pathophysiology in patients with primary Pulmonary hypertension.
- Diabetes and the associated incidence of subclinical atherosclerosis and Coronary artery disease: Implications for management.
- Safety of EBCT contrast injection studies in severe Pulmonary hypertension.
- A simple single slice method for measurement of left and right ventricular enlargement by electron beam tomography.
- Comparison of spiral and electron beam tomography in the evaluation of Coronary calcification in asymptomatic persons.
- Coronary artery motion in electron beam tomography.
- Electron beam computed tomography to detect Coronary artery disease.
- Effect of exercise on left and right ventricular ejection fraction and wall motion.
- Nitrate-enhanced thallium 201 single-photon emission computed tomography imaging in hibernating myocardium.
- Intravenous three-dimensional Coronary angiography using contrast enhanced electron beam computed tomography.
- Primary Pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.
- Variation of Heart rate and electrocardiograph trigger interval during ultrafast computed tomography.
- Disseminated coccidioidomycosis with rapid progression to effusive-constrictive pericarditis.
- Overdosing with prostacyclin in primary Pulmonary hypertension.
- Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary Pulmonary hypertension.
- Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with Pulmonary arterial hypertension: a double-blind, randomized, placebo-contro...
- Beraprost therapy for Pulmonary arterial hypertension.
- Sitaxsentan therapy for Pulmonary arterial hypertension.
- Comparison of LV mass and volume measurements derived from electron beam tomography using cine imaging and angiographic imaging.
- The 6-min walk test (6MW) as an efficacy endpoint in Pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect.
- Ambrisentan therapy for Pulmonary arterial hypertension.
- Quality indicator set for systemic sclerosis.
Schools
Keck School Of Medicine Of The Univ Of Southern California
University Of California San Diego
Harbor UCLA Med Center
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardioversion, Elective
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Ectasia
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACP)
- Fellow (FACC)
- Super Doctor
Education
-
Harbor - UCLA Medical Center -
University of California San Diego -
Keck School of Medicine of USC
Hospital
-
Ronald Reagan UCLA Medical Center -
Harbor-UCLA Medical Center
Drug Facts
| NPI NUMBER | 1316957228 | |
| NPPES Provider LastName | OUDIZ | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 905022047 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 931.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 1.4 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316957228 |
| Last Name Of The Provider | OUDIZ |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
Dr. Michele Del Vicario, MD |
|
|
Dr. Leonard J. Scuderi, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Erol M. Kosar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Castleman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph L. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Juma A. Bharadia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert Cespedes Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles McKay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vijay S. Vaidya, MD
This Doctor is OpenDoctor Recommended.
|